MediSieve was accepted onto the London & Partners’ Business Growth Programme! The free, three-month programme is giving London-based companies the tools they need to survive and thrive during these challenging times - from mentorship and account management, to expert advice and new business opportu...

Recent studies show that patients with the most serious forms of the coronavirus had high levels of something called IL-6, a common inflammatory cytokine, which MediSieve has previously encountered while researching sepsis and cytokine storms.